The Role of Nutrition in Sickle Cell Disease

H I Hyacinth, B E Gee, J M Hibbert, H I Hyacinth, B E Gee, J M Hibbert

Abstract

Finding a widely available cure for sickle cell anemia (HbSS) still remains a challenge one hundred years after its discovery as a genetically inherited disease. However, growing interest in the nutritional problems of the disease has created a body of literature from researchers seeking nutritional alternatives as a means of decreasing morbidity and improving quality of life among HbSS patients. This review demonstrates that over the past 30 years the role of protein/energy deficiency in HbSS has been more clearly defined via direct measurements, leading to the concept of a relative shortage of nutrients for growth and development, despite apparently adequate dietary intakes. Although there is still a paucity of data supporting the efficacy of macronutrient supplementation, it is becoming clearer that recommended dietary allowances (RDAs) for the general population are insufficient for the sickle cell patient. A similar shortage is likely to be true for micronutrient deficiencies, including recent findings of vitamin D deficiency that may be associated with incomplete ossification and bone disease, which are well known complications of HbSS disease. We conclude that there is need for more effort and resources to be dedicated to research (including supplementation studies of larger sample size) aimed at establishing specific RDAs for HbSS patients, much like the specific RDAs developed for pregnancy and growth within the general population.

References

    1. Mehta AB, Hoffbrand AV. Hematology at a glance. 1st edition. Massachusetts: Blackwell publishing; 2000. Hemolytic anemias V Inherited defects of hemoglobin—sickle cell disease; p. 50. chapt. 17.
    1. Feldenzer J, Mears JG, Burns AL, Natta C, Bank A. Heterogeneity of DNA fragment associated with the sickle globin gene. J Clin Invest. 1979;64:751–5.
    1. Kan WY, Dozy AM. Evolution of the hemoglobin S and C genes in world populations. Science. 1980;209:388–91.
    1. Driss A, Kwaku A, Hibbert J, Adamkiewicz T, Stiles JK. Sickle cell disease in the post genomic era: A monogenic disease with a polygenic phenotype. Genomic Insights. 2009;2:23–48.
    1. Brousseau DC, Owens PL, Mosso AL, et al. Acute care utilization and re-hospitalizations for sickle cell disease. JAMA. 2010;303:1288–94.
    1. Davis H, Moore RM, Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep. 1997;112:40–3.
    1. de Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease. Br J Haematol. 2000;108(2):284–9.
    1. Heyman MB, Katz R, Hurst D, et al. Growth retardation in sickle-cell disease treated by nutritional support. The Lancet. 1985;325(8434):903–6.
    1. Tomer A, Kasey S, Connor WE, et al. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost. 2001;85(6):966–74.
    1. Kumar V, Abbas AK, Fausto N. Robins and Cotran pathologic basis of disease. 7th ed. Philadelphia: Elsevier/Saunders; 2005. Disease of organs systems: Red blood cells and bleeding disorders—sickle cell disease; pp. 628–32. chapt. 13.
    1. Lachant NA, Kouichi RT. Antioxidants in sickle cell disease: The in vitro effects of ascorbic acid. Am J Med Sci. 1986;292(1):3–10.
    1. Mitchell MJ, Carpenter GJO, Crosby LE, et al. Growth status in children and adolescents with sickle cell disease. Pediatr Hematol Oncol. 2009;26(4):202–15.
    1. Wang WC, Helms RW, Lynn HS, et al. Effect of hydroxyurea on growth in children with sickle cell anemia: Results of the HUG KIDS study. J Pediatr. 2002;140:225–9.
    1. Goldberg MA, Brugnara C, Dover GJ, et al. Treatment of sickle cell anemia with hydroxyurea, erythropoietin. N Eng J Med. 1990;323(6):366–72.
    1. Al-Saqladi A-WM, Cipolotti R, Fijnvandraat K, et al. Growth and nutritional status of children with homozygous sickle cell disease. Ann Trop Paediatr. Internat Child Health. 2008;28:165–89.
    1. Badaloo A, Jackson AA, Jahoor F. Whole body protein turnover and resting metabolic rate in homozygous sickle cell disease. Clin Sci. 1989;77(1):93–7.
    1. Barden EM, Zemel BS, Kawchak DA, et al. Total and resting energy expenditure in children with sickle cell disease. The J Pediatr. 2000;136(1):73–9.
    1. Khan S, Steven JT, Dinko N. Zinc deficiency causing hyperammonemia and encephalopathy in a sickle cell patient. Chest {meeting abstract} 2009;136(4):37S–7d.
    1. Natta CL, Reynolds RD. Apparent vitamin B6 deficiency in sickle cell anemia. Am J Clin Nutr. 1984;40:235–39.
    1. Soliman AT, El-Zalabany M, Amer M, et al. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: A comparative study. J Trop Pediatr. 1999;45(1):23–30.
    1. Reed JD, Reddin-Lallinger R, Orringer EP. Nutrition and sickle cell disease. Am J Hematol. 1987;24:441–55.
    1. Prasad AS. Malnutrition in sickle cell disease patients. Am J Clin Nutr. 1997;66(2):423–4.
    1. Gray NT, Bartlett JM, Kolasa KM, et al. Nutritional status and dietary intake of children with sickle cell anemia. J Pediatr Hematol Oncol. 1992;14(1):57–61.
    1. Henderson RA, Jose MS, George JD. Prevalence of impaired growth in children with homozygous sickle cell anemia. The Am J Med Sci. 1994;307(6):405–7.
    1. Serjeant GR, Singhal A, Hambleton IR. Sickle cell disease and age at menarche in Jamaican girls: Observations from a cohort study. Arch Dis Child. 2001;85(5):375–8.
    1. Barden EM, Kawchak DA, Ohene-Frempong K, et al. Body composition in children with sickle cell disease. Am J Clin Nutr. 2002;76(1):218–25.
    1. Silva CM, Marcos BV. Growth deficits in children with sickle cell disease. Arch Med Res. 2005;33(3):308–12.
    1. Ashcroft MT, Serjeant GR, Desai P. Heights, weights and skeletal age of Jamaican adolescents with sickle cell anemia. Arch Dis Child. 1972;47:519–24.
    1. Ashcroft MT, Serjeant GR. Body habitus of Jamaican adults with sickle cell anemia. Southern Med J. 1972;65:579–82.
    1. World Health Organization. Energy and protein requirements. Geneva, Switzerland: 1985. Technical Report Series # 744.
    1. Archer DR, Stiles JK, Newman GW, et al. C-reactive protein and interleukin-6 are decreased in transgenic sickle cell mice fed a high protein diet. J Nutr. 2008;138(6):1148–52.
    1. Dasgupta T, Robert PH, Dhananjay KK. Protective effect of arginine on oxidative stress in transgenic sickle mouse models. Free Radical Biol Med. 2006;41(12):1771–80.
    1. Romero JR, Suzuka SM, Nagel RL, et al. Arginine supplementation of sickle transgenic mice reduces red cell density and gardos channel activity. Blood. 2002;99(4):1103–8.
    1. Kaul DK, Zang X, Dasgupta T, et al. Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress. Am J Pediatr—Heart Circul Physiol. 2002;295(1):H39–47.
    1. Fasipe FR, Ubawike AE, Eva R, et al. Arginine supplementation improves rotorod performance in sickle transgenic mice. Hematol. 2004;9:301–5.
    1. Styles LA, Kuypers F, Kesler K, et al. Arginine therapy does not benefit children with sickle cell anemia: Results of the comprehensive sickle cell multi-center study. 35th convention of National Sickle Cell Disease Program and the Sickle Cell Disease Association of America; Washinton, DC. 2007. p. 114.
    1. Morris CR, Morris SM, Hagar W, et al. Arginine therapy: A new treatment for pulmonary hypertention in sickle cell disease? Am J Respir Crit Care. 2003;168:63–9.
    1. Williams R, Olivi S, Li SC, et al. Oral glutamine supplementation decreases resting energy expenditure in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol. 2004;26:619–25.
    1. Enwonwu CO, Xu XX, Turner E. Nitrogen metabolism in sickle cell anemia: Free amino acids in plasma and urine. Am J Med Sci. 1990;300:366–71.
    1. Singhal A, Parker S, Linsell L, et al. Energy intake and resting metabolic rate in preschool Jamaican children with homozygous sickle cell disease. Am J Clin Nutr. 2002;75:1093–7.
    1. Hibbert JM, Creary MS, Gee BE, et al. Erythropoiesis and myocardial energy requirements contribute to the hypermetabolism of childhood sickle cell anemia. J Pediatr Gastroenterol and Nutr. 2006;43(5):680–7.
    1. Hibbert JM, Hsu LL, Bhathena SJ, et al. Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med. 2005;230(1):68–74.
    1. Borel MJ, Buchowski MS, Turner EA, et al. Protein turnover and energy expenditure increase during exogenous nutrient availability in sickle cell disease. Am J Clin Nutr. 1998;68(3):607–14.
    1. Salman EK, Haymond MW, Sager BK, et al. Protein and energy metabolism in prepubertal children with sickle cell anemia. Pediatr Res. 1996;40(1):34–40.
    1. Jackson AA, Landman JP, Stevens MC, Serjeant GR. Urea kinetics in adults with homozygous sickle cell disease. Eur J Clin Nutr. 1988;42:491–6.
    1. Hibbert JM, Forrester T, Jackson AA. Urea kinetics: comparison of oral and intravenous dose regimens. Eur J Clin Nutr. 1992;46(6):405–9.
    1. Prasad AS, Meftah S, Abdullah J, et al. Serum thymulin in human zinc deficiency. J Clin Invest. 1988;82(4):1202–10.
    1. Prasad AS. Zinc and immunity. Mol Cell Bioch. 1998;188(1):63–9.
    1. Prasad AS, Zafrallah TC. Zinc Supplementation and growth in sickle cell disease. Ann Intern Med. 1984;100(3):367–71.
    1. Zemel BS, Kawchak DA, Fung EB, et al. Effect of zinc supplementation on growth and body composition in children with sickle cell disease. Am J Clin Nutr. 2002;75:300–7.
    1. Rao NJ, Sur AM. Iron deficiency in sickle cell disease. Acta Paediatr Scand. 1981;69:963–8.
    1. Mohanty D, Mukherjee MB, Colah RB, et al. Iron deficiency anemia in sickle cell disorders in India. Indian J Med Res. 2008;127(4):366–9.
    1. Okeahialam TC, Obi GO. Iron deficiency in sickle cell anemia in Nigerian children. Ann Trop Pediatr. 1982;2:89–92.
    1. Vichinsky E, Kleman K, Embury S, et al. The diagnosis of iron deficiency anemia in sickle cell disease. Blood. 1981;58(5):963–8.
    1. Brown K, Subramony C, May W, et al. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy. J Pediatr Hematol Oncol. 2009;31(5):309–12.
    1. Belcher JD, Marker PH, Geiger P, et al. Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia. J Lab Clin Med. 1999;133(6):605–12.
    1. King SM, Donangelo CM, Knutson MD, et al. Daily supplementation with iron increases lipid peroxidation in young women with low iron stores. Exp Biol Med. 2008;233(6):701–7.
    1. McCullough KD, Wally JB. The dose-dependent effects of chronic iron overload on the production of oxygen free radicals and vitamin e concentrations in the liver of a murine model. Biological Res Nurs. 2007;8(4):300–4.
    1. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J Med. 1998;339:5–11.
    1. Adams RJ, Brambilla D, STOP 2 investigators Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353:2743–5.
    1. Prasad AS. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol. 2008;43(5):370–7.
    1. Prasad AS, Schoomaker EB, Ortega J, et al. Zinc deficiency in sickle cell disease. Clin Chem. 1975;21(4):582–7.
    1. Prasad AS. Zinc deficiency in patients with sickle cell disease. Am J Clin Nutr. 2002;75(2):181–2.
    1. Prasad AS, Abbasi AA, Rabbani P, et al. Effect of zinc supplementation on serum testosterone level in adult male sickle cell anemia subjects. Am J Hematol. 1981;10:119–27.
    1. Prasad AS, Beck FW, Kaplan J, et al. Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease. Am J Hematol. 1999;61:194–202.
    1. Leonard MB, Zemel BS, Kawchak DA, et al. Plasma zinc status, growth, and maturation in children with sickle cell disease. The J Pediatr. 1998;132(3):467–71.
    1. Prasad AS. Effect of zinc on hyperammonemia in sickle cell anemia subjects. Am J Hematol. 1979;7:323–7.
    1. Khan S, Steven JT, Dinko N. Zinc deficiency causing hyperammonemia and encephalopathy in a sickle cell patient. Chest. {meeting abstract} 2009;136(4):37S–7d.
    1. Serjeant GR, Galloway RE, Gueri MC. Oral zinc sulphate in sickle-cell ulcers. The Lancet. 1970;2:891–3.
    1. Trent JT, Robert SK. Leg ulcers in sickle cell disease. Advances Skin and Wound Care. 2004;17(8):410–6.
    1. Bao B, Prasad AS, Beck FWJ, et al. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients. Translational Research. 2008;152(2):67–80.
    1. Behera SK, Satpathy KN, Patnaik BK, et al. Serum copper in sickle cell disease. Indian Pediatr. 1981;18:395–9.
    1. Pellegrini BJA, Kerbauy J, Fisberg M. Zinc, copper and iron and their interrelations in the growth of sickle cell patients. Arch. Latinoam Nutr. 1995;45(3):198–203.
    1. Akenami FO, Aken’Ova YA, Osifo BO. Serum zinc, copper and magnesium in sickle cell disease at Ibadan, southwestern Nigeria. Afr J Med Sci. 1999;28(3–4):137–9. [1]
    1. Prasad AS, Ortega J, Brewer GJ, et al. Trace elements in sickle cell disease. JAMA. 1976;235:2396–8.
    1. Schaeffer K, Aikens J, Williamson M, et al. The distribution of copper in sickling erythrocytes as determined by an IBM cell separator. J Natl Med Assoc. 1981;73:653–6.
    1. Prasad AS, Brewer GJ, Schoomaker EB, et al. Hypocupremia induced by zinc therapy in adults. JAMA. 1978;240:2166–8.
    1. Underwood EJ. Trace elements in human and animal nutrition. 4th ed. New York, NY: Academic Press Inc; 1977. pp. 56–108.
    1. King JC, Cousins RJ. Zinc. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editors. Modern nutrition in health and disease. 10th ed. Baltimore: Lippincott Williams and Wilkins; 2006. pp. 271–85.
    1. Hasanato RMW. Zinc & antioxidant vitamin deficiency in patients with severe sickle cell anemia. Ann Saudi Med. 2006;26:17–21.
    1. Natta CL, Tatum VL, Chow CK. Antioxidant status and free-radical induced oxidative damage of sickle erythrocytes. Ann NY Acad Sci. 1992;669:365–7.
    1. Sandstead HH. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am J Clin Nutr. 1995;61(Suppl):621S–4.
    1. Oladipo OO, Temiye EO, Ezeaka VC, et al. Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease. West Afr J Med. 2005;24(2):120–3.
    1. Zehtabchi S, Sinert R, Rinnert S, et al. Serum ionized magnesium levels and ionized calcium-to-magnesium ratios in adult patients with sickle cell anemia. Am J Hematol. 2004;77(3):215–22.
    1. de Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin Invest. 1997;100(7):1847–52.
    1. Brousseau DC, Scott JP, Hillery CA, et al. The effect of magnesium on length of stay for pediatric sickle cell pain crisis. Acad Emerg Med. 2004;11(9):968–72.
    1. Rinehart J, Gulcicek EE, Joiner CH, et al. Determinants of erythrocyte hydration. Curr Opin Hematol. 2010;17:191–7.
    1. Hankins JS, Wynn LW, Brugnara C, et al. Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia. Br J Haematol. 2008;140:80–5.
    1. Lindenbaum J. Folic acid requirement in situations of increased need. In: Workshop on Human Folate Requirements, editor. Folic acid: biochemistry and physiology in relation to the human nutrition requirement. Washington, DC: National Academy of Sciences; 1977. pp. 256–76.
    1. MacIver JR, Went LM. Sickle cell anaemia complicated by megaloblastic anaemia of infancy. BMJ. 1960;1:775–9.
    1. Alperin JB. Folic acid deficiency complicating sickle cell anemia: A study on the response to titrated doses of folic acid. Arch Intern Med. 1967;120:298–306.
    1. Rabb LM, Grandison Y, Mason K, et al. A trial of folate supplementation in children with homozygous sickle cell disease. Br J Haematol. 1983;54:589–94.
    1. Dhar M, Bellevue R, Carmel R. Pernicious anemia with neuropsychiatric dysfunction in a patient with sickle cell anemia treated with folate supplementation. N Engl J Med. 2003;348:2204–7.
    1. Carmel R, Bellevue R, Kelman Z. Low cobalamin levels associated with sickle cell disease: Contrasting origins and clinical meanings in two instructive patients. Am J Hematol. 2010;85:436–9.
    1. Hoffer LJ, Carmel R. Folate supplementation in sickle cell anemia. N Engl J Med. {correspondence} 2003;349:813.
    1. Nelson MC, Zemel BS, Kawchak DA, et al. Vitamin B6 status of children with sickle cell disease. J Pediatr Hematol Oncol. 2002;24(6):463–9.
    1. Balasa VV, Kalinyak KA, Bean JA, et al. Hyperhomocysteinemia is associated with low plasma pyridoxine levels in children with sickle cell disease. J Pediatr Hematol Oncol. 2002;24(5):374–9.
    1. van der Dijs FP, Schnog JJ, Brouwer DA, et al. Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients. Am J Hematol. 1998;59(3):192–8.
    1. Dhar M, Bellevue R, Brar S, et al. Mild hyperhomocysteinemia in adult patients with sickle cell disease: A common finding unrelated to folate and cobalamin status. Am J Hematol. 2004;76:114–20.
    1. Segal JB, Miller ER, III, Brereton NH, et al. Concentrations of B vitamins and homocysteine in children with sickle cell anemia. South Med J. 2004;97(2):149–55.
    1. Ohnishi ST, Ohnishi T, Ogunmola GB. Sickle cell anemia: A potential nutritional approach for a molecular disease. Nutr. 2000;16(5):330–8.
    1. Jaja SI, Kehinde MO, Ogungbemi SI. Cardiac and autonomic responses to change in posture or vitamin C supplementation in sickle cell anemia subjects. Pathophysiol. 2008;15(1):25–30.
    1. Broxson EH, Jr, Sokol RJ, Githens JH. Normal vitamin E status in sickle hemoglobinopathies in Colorado. Am J Clin Nutr. 1989;50(3):497–503.
    1. Marwah SS, Blann AD, Rea C, et al. Reduced vitamin E antioxidant capacity in sickle cell disease is related to transfusion status but not to sickle crisis. Am J Hematol. 2002;69(2):144–6.
    1. Wang F, Wang T, Lai J, et al. Vitamin E inhibits hemolysis induced by hemin as a membrane stabilizer. Biochem Pharmacol. 2006;71(6):799–805.
    1. Almeida A, Roberts I. Bone involvement in sickle cell disease. Br J Haematol. 2005;129(4):482–90.
    1. Buison AM, Kawchak DA, Schall JI, et al. Low vitamin D status in children with sickle cell disease. J Pediatr. 2004;145(5):622–7.
    1. Rovner AJ, Stallings VA, Kawchack DA, et al. High risk of vitamin D deficiency in children with sickle cell disease. J Am Dietetic Assoc. 2008;108(9):1512–6.
    1. Buison AM, Kawchack DA, Schall JI, et al. Bone Area and Bone Mineral Content Deficits in Children With Sickle Cell Disease. Pediatr. 2005;116(4):943–49.
    1. Chapelon E, Garabedian M, Brousse V, Souberbielle JC, Bresson JL, de Montalembert M. Osteopenia and vitamin D deficiency in children with sickle cell disease. Eur J Haematol. 2009;83(6):572–8.
    1. Adewoye AH, Chen TC, Ma Q, et al. Sickle cell bone disease: Response to vitamin D and calcium. Am J Hematol. 2008;83(4):271–4.
    1. Goodman BM, III, Artz N, Radford B, et al. Prevalence of vitamin D deficiency in adults with sickle cell disease. J Natl Med Assoc. 2010;102(4):332–5.
    1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.
    1. Reid M, Badaloo A, Forrester T, Jahoor F. In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease. Am J Physiol Endocrinol Metab. 2006;291(1):E73–9.
    1. Kawchak DA, Schall JI, Zemel BS, et al. Adequacy of dietary intake declines with age in children with sickle cell disease. J Am Dietetic Assoc. 2008;107(5):843–8.
    1. Rich TA, Innominato P, Mormont MC, et al. Performance status, global quality of life, fatigue, and appetite loss are correlated with serum TGFa and IL-6 in patients with metastatic colorectal cancer (MCC) {suppl to ASCO meeting abstracts} 2004;22(14):8024.
    1. van Lettow M, van der Meer JWM, West CE, et al. Interleukin-6 and human immunodeficiency virus load, but not plasma leptin concentration, predict anorexia and wasting in adults with pulmonary tuberculosis in malawi. J Clin Endocrinol Metab. 2005;90(8):4771–6.
    1. Belcher JD, Bryant CJ, Nguyen J, et al. Transgenic sickle mice have vascular inflammation. Blood. 2003;101(10):3953–9.
    1. Okpala I. Leukocyte adhesion and the pathophysiology of sickle cell disease. Curr Opin Hematol. 2006;13(1):40–4.
    1. Rahbar F, Scott RB, Jily P. Studies in sickle cell anemia: Preliminary observation on gastrointestinal digestion and absorption. J Natl Med. Assoc. 1977;69:1003–4.
    1. Singhal A, Thomas P, Cook R, Wierenga K, Serjeant G. Delayed adolescent growth in homozygous sickle cell disease. Arch Dis Child. 1994;71(5):404–8.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere